LUCI DAVID P 4
4 · Acurx Pharmaceuticals, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2025-01-06$1.01/sh+49,261$50,000→ 1,097,458 total - Purchase
Warrants for Common Stock
2025-01-06+49,261→ 49,261 totalExercise: $0.90From: 2025-01-07Exp: 2030-01-07→ Common Stock (49,261 underlying)
Holdings
- 35,000(indirect: By Children)
Common Stock
- 15,083(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
- [F2]Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.